Related Experiment Video
Updated: Feb 24, 2026

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
Integrated Genomic Medicine: A Paradigm for Rare Diseases and Beyond
1The Translational Genomics Research Institute, Phoenix, AZ, United States; The J. Craig Venter Institute, La Jolla, CA, United States; The University of California, San Diego, San Diego, CA, United States.
Integrating advanced biomedical technologies offers the best approach to tailor treatments for individual patients, especially those with rare diseases. This personalized medicine strategy requires new scientific paradigms and infrastructure for improved patient health outcomes.
Area of Science:
- Biomedical Science
- Genomics
- Personalized Medicine
Background:
- Individualized medicine relies on tailoring treatments to a patient's unique profile.
- Modern biomedical technologies like DNA sequencing and stem cell assays have advanced this field.
- Current successes are often isolated, limiting comprehensive patient care.
Purpose of the Study:
- To argue for the integrated use of biomedical technologies in focused patient studies.
- To explore the potential of integrated technologies for rare disease treatment strategies.
- To propose new scientific paradigms and infrastructure for personalized medicine.
Main Methods:
- Reviewing the capabilities of current biomedical technologies.
- Analyzing the benefits of combining technologies for individual patient studies.
- Discussing the necessity of new infrastructure, databases, and training programs.
Main Results:
- Integrated use of technologies offers superior tailoring of interventions.
- This approach is crucial for studying rare diseases due to limited patient cohorts.
- New paradigms are needed, emphasizing patient health improvement over technology advancement.
Conclusions:
- Integrated biomedical technologies are essential for advancing personalized medicine.
- Focusing on integrated patient studies, particularly for rare diseases, is critical.
- The described paradigm can potentially extend to common diseases, enhancing overall patient care.
More Related Videos
09:37Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
Published on: August 15, 2019
13:24Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
Related Concept Videos
Genomics
Pharmacogenomics: Identification of New Drug Targets
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Pharmacogenetics and Pharmacogenomics: Overview